|
Analyzing inmuno-related adverse event: A real-world DATA study. |
|
|
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche |
|
|
Consulting or Advisory Role - Novartis |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Sanofi |
|
Aranzazu Gonzalez del Alba |
Honoraria - Astellas Pharma; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi/Aventis |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Speakers' Bureau - Ipsen; Janssen-Cilag; Pfizer; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; PFIZER; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |